Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Why retail investors in JPMorgan Russian Securities are sounding the alarm on changes

The board of JPMorgan Russian Securities (JRS) has moved to allay investor fears linked to a looming change of mandate for the investment trust.
With trading in Russian stocks suspended thanks to the country’s invasion of Ukraine, the board revealed on 27 October that it was broadening the investment objective to encompass Central, Eastern and Southern Europe (including Russia), the Middle East and Africa.
The deadline to vote on these proposals on some investment platforms is likely to be several days in advance of the 23 November shareholder meeting.
Ordinary investors in the trust, some of which have contacted Shares directly, are concerned about the risks of a capital raise and of its Russian holdings being sold off at a significant discount.
One holder of the trust, Joseph, told Shares he was part of a group of around 100 private investors owning more than 5% of JPMorgan Russian Securities combined.
To facilitate the change of mandate there was a general concern the trust would pursue a capital raise. The board has acknowledged this concern and in a stock market announcement on 7 November said that there ‘are currently no plans to issue shares or raise capital, even in the event the current prohibitions on the trading and receipt of dividends on Russian securities are lifted’.
There was also a nod to the existing shareholders’ pre-emption rights, in other words first refusal on the issue of any new shares, and on promoting the success of the trust for the benefit of ‘all members’.
However, beyond this risk of being diluted by any share issue, Joseph noted ‘the new investment objective may impose a limit on the Russian exposure of the trust’, though the trust's board has denied this will be the case.
He added: ‘When the Moscow Stock Exchange reopens to foreigners there may be a rush to liquidate Russian holdings by Western investors which may depress share prices.’
He expressed the worry that this could result in the trust selling shares below their intrinsic value. Its current share price is just 79p and the shares trade at a near 70% premium to net asset value.
Joseph said a current investment in a money market fund covers the running costs of the trust and therefore it ‘could operate in the status quo indefinitely while it waits for the reopening of Moscow Stock Exchange to foreigners’.
When contacted by Shares on this point JPMorgan Asset Management declined to comment beyond the statement already put
out by the trust’s board.
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
Issue contents
Feature
Great Ideas
News
- Mid-cap stocks reverse losing streak versus FTSE 100
- Why retail investors in JPMorgan Russian Securities are sounding the alarm on changes
- Veterinary group CVS plans to double profitability over the next five years
- Falling house prices and higher sales cancellations: why property market-related shares are down again
- Chinese stocks surge on prospect of end to strict Covid measures
- Hasbro hurt as toy demand drops following price hikes
- Strong customer demand puts Caterpillar shares 10% ahead on the year